![Ravi Savarirayan](/sites/default/files/styles/medium/public/bn-di-person/Ravi%20Savarirayan.jpeg?itok=yUkAwO5B)
Professor Ravi Savarirayan has been a consultant clinical geneticist at the Victorian Clinical Genetics Services since August 1999, as well as professor and research group leader of skeletal biology and disease at the Murdoch Children's Research Institute since September 2000.
He has been a founding member of the Skeletal Dysplasia Management Consortium since January 2011, and chair of the specialist advisory committee in clinical genetics at the Royal Australasian College of Physicians since February 2009. He was president of the International Skeletal Dysplasia Society from July 2009 to June 2011, and has been an invited member of several international working committees on constitutional diseases of bone.
Prof Savarirayan's primary research focus is on inherited disorders of the skeleton causing short stature, arthritis and osteoporosis; and he leads numerous clinical therapy trials for these conditions. He has published over 180 peer-reviewed articles, collaborating with peers from over 30 countries.
Prof Savarirayan has been on the editorial board of Human Mutation since January 2009, European Journal of Human Genetics since July 2007, American Journal of Medical Genetics since December 2011, and the Journal of Medical Genetics since June 2005.
He was named one of the "Brilliant Minds" of the Murdoch Children's Research Institute over the past 30 years.